(Q52065697)

English

The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial.

scientific article published in April 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial. (English)

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

author name string

R D MacArthur

1

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

L Chen

2

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

D L Mayers

3

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

C L Besch

4

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

R Novak

5

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

M van den Berg-Wolf

6

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

T Yurik

7

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

G Peng

8

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

B Schmetter

9

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

B Brizz

10

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

D Abrams

11

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

CPCRA 058 FIRST Trial Study Team

12

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

language of work or name

0 references

publication date

1 April 2001

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

Contemporary Clinical Trials

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

22

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

2

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

176-190

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

British HIV Association guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

British HIV Association guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sample size determination in clinical trials with time-dependent rates of losses and noncompliance

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900111-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0197-2456(01)00111-8

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

1 reference

Europe PubMed Central

21 April 2018

http://europepmc.org/abstract/MED/11306155

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52065697&oldid=1403555139"